RESUMEN
This article chronicles the barriers encountered as a multidisciplinary department undertook management restructuring. Barriers that are addressed include lack of a sense of urgency; confusion and fear regarding the changing roles of both staff and managers; insufficient development of coaching skills; and lack of alignment of performance appraisals, outcomes, and rewards. Insights gained and strategies to deal with these barriers are discussed.
Asunto(s)
Reestructuración Hospitalaria/organización & administración , Supervisión de Enfermería/organización & administración , Grupo de Atención al Paciente/organización & administración , Garantía de la Calidad de Atención de Salud/organización & administración , Actitud del Personal de Salud , Conocimientos, Actitudes y Práctica en Salud , Humanos , Perfil Laboral , Personal de Enfermería en Hospital/organización & administración , Personal de Enfermería en Hospital/psicología , Innovación Organizacional , Evaluación de Programas y Proyectos de Salud , Calidad de la Atención de SaludRESUMEN
The development of colorectal carcinoma from adenomas is recognized as the dominant mechanism of colon carcinogenesis. However, early colon carcinomas are being increasingly detected which have no adenomatous elements in their vicinity, and which, despite their small size, already show submucosal invasion. Such tumours (so-called 'de novo' carcinomas) have renewed consideration of the de novo colorectal carcinogenesis pathway. The goal of this study was to evaluate the expression of tumour suppressor gene p53 and apoptosis control gene bcl-2 in de novo carcinomas, compared with early carcinomas developing in the background of an adenoma (ex-adenoma). Fifty cases each of de novo and ex-adenoma carcinomas (pT1) were studied. p53 expression was significantly higher in the de novo carcinomas than in the ex-adenoma carcinomas (62 per cent vs. 42 per cent), while bcl-2 tended to be weaker in the de novo than in the ex-adenoma carcinomas. These differences' support the concept that de novo carcinomas are a unique pathological entity, with a phenotype reflecting their more aggressive behaviour.